GlaxoSmithKline | Ativos



Assets Alterar Data
AbbVie USD 135.16B 8.26B 2024-12
Alcon AG USD 31.01B 661M 2025-03
Almirall EUR 2.31B 88.18M 2025-06
Amgen USD 89.37B 2.47B 2025-03
argenx SE 6.2B 5.72B 2024-12
AstraZeneca USD 106.25B 2.22B 2025-03
Bayer EUR 109.18B 1.67B 2025-03
Biogen USD 28.03B 16.2M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Fresenius EUR 43.21B 343M 2025-03
Fresenius Medical Care EUR 32.74B 832M 2025-03
Galapagos EUR 3.82B 203.72M 2025-06
Genmab DKK 6.59B 39.22B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
GRIFOLS EUR 20.98B 426.68M 2025-03
Hikma Pharmaceutical USD 5.13B 286M 2024-12
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 49.37B 2.19B 2025-03
Merck USD 115.12B 1.98B 2025-03
Novartis USD 104.4B 4.45B 2025-06
Novo Nordisk 489.16B 91.72B 2025-03
Orion EUR 1.65B 56M 2025-06
Pfizer USD 208.03B 5.37B 2025-03
Philips EUR 27.17B 1.81B 2025-03
Recordati EUR 5.17B 962.56M 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
Smith & Nephew USD 10.35B 188M 2024-12
UCB EUR 17.35B 1.72B 2024-12


GlaxoSmithKline Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.